DKK 3.0
(-4.46%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 11.16 Million DKK | 66.45% |
2022 | 12.21 Million DKK | 75.46% |
2021 | 6.96 Million DKK | -30.21% |
2020 | 9.92 Million DKK | 112.2% |
2019 | 4.56 Million DKK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 3.74 Million DKK | 0.0% |
2024 Q1 | 3.74 Million DKK | -43.36% |
2023 Q4 | 6.89 Million DKK | 96.51% |
2023 FY | - DKK | 66.45% |
2023 Q3 | 3.5 Million DKK | -73.89% |
2023 Q2 | 13.43 Million DKK | 97.33% |
2023 Q1 | 6.8 Million DKK | 45.64% |
2022 Q2 | 1.77 Million DKK | 81.56% |
2022 Q4 | 4.67 Million DKK | 0.0% |
2022 FY | - DKK | 75.46% |
2022 Q3 | 4.67 Million DKK | 163.62% |
2022 Q1 | 976.71 Thousand DKK | 17.58% |
2021 Q1 | 2.43 Million DKK | 0.0% |
2021 Q3 | 830.65 Thousand DKK | -82.28% |
2021 Q4 | 830.65 Thousand DKK | 0.0% |
2021 FY | - DKK | -30.21% |
2021 Q2 | 4.68 Million DKK | 92.59% |
2020 FY | - DKK | 112.2% |
2019 FY | - DKK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Flügger group A/S | 236.36 Million DKK | 95.277% |
Novozymes A/S | 5.47 Billion DKK | 99.796% |
SP Group A/S | 455.65 Million DKK | 97.55% |